Back to search
FDAFDA · Food and drugs·Recall number Z-1604-2024

Redux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme.

Published May 1, 2024 · Recall initiated: March 22, 2024

Summary

FDA records medical device Class II recall Z-1604-2024, published May 1, 2024 and initiated March 22, 2024. Recalling firm: Parker Laboratories, Inc.; Status: Ongoing; Reported quantity: 217 cases (1,085 Inner Boxes; 10,850 Eaches); Lot: Product No. 66-04; UDI: 20855683006399 (Master), 10855683006392 (Inner Box), 00855683006395 (Each); Lot No. (Expiration Date): A1122010 (11/29/25) and A0523002 (5/12/26). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product demonstrates low viscosity.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Parker Laboratories, Inc.
Distributor
Worldwide distribution - US Nationwide in the states of CA, CO, FL, GA, IL, MD, MI, MN, NC, NE, NY, OH, PA, SC, & TX. The countries of AU, CA, OM, & SA.
Lot
Product No. 66-04; UDI: 20855683006399 (Master), 10855683006392 (Inner Box), 00855683006395 (Each); Lot No. (Expiration Date): A1122010 (11/29/25) and A0523002 (5/12/26).
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Redux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme. recalled?

Yes. FDA published recall Z-1604-2024 on May 1, 2024. Reported hazard: Product demonstrates low viscosity.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail